← All Sponsors
SPONSOR

Gachon University Gil Medical Center

Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEFHFpEFGroup 2 Pulmonary Hypertension

Clinical Trials by Gachon University Gil Medical Center

NCT07147114 Phase 4
Recruiting

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Combined Pre- and Post-capillary Pulmonary Hypertension
South Korea View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology